Royalty Pharma Dividend yield

Royalty Pharma is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Royalty Pharma is a company from USA, and his stocks are publicly traded.

Royalty Pharma stock dividend

Royalty Pharma paid a total dividend of 358 million USD last year, for a market value of 13,359 millions (Market Cap 11,049 millions). Royalty Pharma dividend per share is 0.80 USD, and his stock market price 29.82 USD.

According to the chart below, where dividend yield is displayed, Royalty Pharma has a dividend yield of 2.68%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare Royalty Pharma stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best USA dividend stocks list.

Royalty Pharma Dividend Payout

About the ability of Royalty Pharma to maintain his current dividend of USD 0.80 per share, an amount that accounts for 2.68%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Royalty Pharma payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

higher than the dividend per share paid by the company of USD 0.80, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Royalty Pharma, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Royalty Pharma Dividend History

Below you will find a table with the historical evolution of Royalty Pharma's dividend stock, both in percentage and in USD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	USD	Paypout	Shares*
Present	2.68%	0.80	0.00%	448
2022	1.92%	0.76	52.05%	441
2021	1.71%	0.68	80.00%	427

*In millions

Royalty Pharma Stock performance

Finally, last moth Royalty Pharma showed a return of -5.00% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -28.70% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.